AstraZeneca (AZN) To Buy Cancer Firm KuDos Pharmaceutical Limited For $210 Million
12/23/2005 10:21:12 AM
More...
|
Novacea Begins Phase 1/2 Trial of Anti-Cancer Agent Banoxantrone (AQ4N) In Patients With Lymphoma
10/19/2005 5:13:13 PM
More...
|
Novacea Announces Three Presentations On Anti-Cancer Agent, Banoxantrone (AQ4N), At American Association for Cancer Research Meeting
10/19/2005 5:12:42 PM
More...
|
Novacea To Present At 46th Annual American Society of Hematology (ASH) Meeting
10/19/2005 5:12:20 PM
More...
|
KuDos Pharmaceutical Limited Release: AQ4N Well Tolerated In First Phase I Report
10/19/2005 5:11:38 PM
More...
|
Novacea Licenses Novel Anti-Cancer Product Candidate From KuDos Pharmaceutical Limited
10/19/2005 5:09:29 PM
More...
|
First Patient Treated With New KuDos Pharmaceutical Limited Oral Anticancer Agent
10/19/2005 5:09:00 PM
More...
|